Skip to main content
. 2008 Jun 10;295(2):E407–E412. doi: 10.1152/ajpendo.90397.2008

Table 1.

Subject characteristics

Variable
Women (n = 33)
Men (n = 40)
Baseline Change Baseline Change
Age, yr 54.0±5.6 50.9±6.4*
Race
    Caucasian 27 (82) 33 (83)
    African-American 5 (15) 5 (13)
    Other 1 (3) 2 (5)
Body mass, kg 77.2±10.6 −0.8±2.5 94.4±10.8* −2.4±2.5*
BMI, kg/m2 29.8±2.8 −0.3±1.0 30.4±2.5 −0.8±0.8*
Exercise group
    Low amount/moderate intensity 10 (30) 8 (20)
    Low amount/vigorous intensity 13 (39) 16 (40)
    High amount/high intensity 10 (30) 16 (40)
Adherence, % 90.8±10.4 89.9±11.0
Relative peak V̇o2, ml·kg−1·min−1 23.9±3.6 2.3±1.9 32.8±3.8* 4.4±3.4*
HDL, mg/dl 60.7±15.5 0.4±6.4 40.8±9.4* 1.9±5.2
LDL, mg/dl 129.5±22.2 0.0±14.1 119.4±20.2* −0.2±18.9
HDL size, nm 9.14±0.37 −0.01±0.11 8.74±0.22* 0.02±0.19
LDL size, nm 21.25±0.63 0.00±0.37 20.45±0.70* 0.13±0.42
Triglyceride, mg/dl 130.9±71.6 −9.5±54.2 156.4±67.7 −21.1±55.8
Thigh IMAT, cm2 9.77±4.45 −0.55±1.34 7.55±3.25* −0.55±1.28
Thigh SAT, cm2 124.71±34.84 −5.59±11.49 65.82±18.10* −3.96±7.53
VAT, cm2 141.60±60.12 −2.71±27.93 204.89±60.93* −23.3±34.68*
Fasting glucose, mg/dl 95.0±11.7 0.2±8.4 95.4±8.3 −0.3±8.5
Fasting insulin, μU/ml 8.3±4.7 −1.6±2.9 11.4±9.3 −1.6±5.1
SI, mU·L−1·min−1 3.8±1.8 0.9±2.8 2.5±1.9* 1.2±1.4

Values are given as means ± SD and frequency (%). Baseline SI given as geometric mean ± geometric SD, as distribution was not normal. Percentages may not total 100% due to rounding. BMI, body mass index; IMAT, intermuscular adipose tissue; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; SI, insulin sensitivity index derived from iv glucose tolerance test with minimal-model analysis (12). Adherence was calculated as the number of minutes of exercise at the appropriate intensity divided by the prescribed number of minutes. Proportions of self-identified race and exercise group by sex were compared using χ2 tests of association. Significance of within- and between-sex differences was otherwise assessed with two-tailed t-tests.

*

Significant sex difference at P < 0.05;

significant within-sex change with training at P < 0.05.